Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Azithromycin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
NCT05842681Recruiting
- Sponsor
- Assiut University
- Start
- Jun 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of azithromycin in idiopathic pulmonary fibrosis (IPF) (4 arms), sponsored by Assiut University. Primary endpoint: Hospital stay. Started Jun 2023; status: recruiting.
02
Drugs
azithromycin
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT05842681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05842681.